Page last updated: 2024-11-01

niclosamide and Osteosarcoma

niclosamide has been researched along with Osteosarcoma in 3 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"Osteosarcoma is a highly common malignant bone tumor."5.72Niclosamide Suppresses Migration and Invasion of Human Osteosarcoma Cells by Repressing TGFBI Expression via the ERK Signaling Pathway. ( Hsieh, YH; Lin, CW; Lu, KH; Yang, JS; Yang, SF; Yeh, CB; Yeh, LT, 2022)
"Niclosamide was found to induce the arrest of S and G2/M phase in U2OS cells and G2/M in MG-63 cells."5.42Niclosamide inhibits the proliferation of human osteosarcoma cell lines by inducing apoptosis and cell cycle arrest. ( Li, Z; Qi, B; Sun, S; Wang, W; Yu, A; Yu, Y, 2015)
"Osteosarcoma is a highly common malignant bone tumor."1.72Niclosamide Suppresses Migration and Invasion of Human Osteosarcoma Cells by Repressing TGFBI Expression via the ERK Signaling Pathway. ( Hsieh, YH; Lin, CW; Lu, KH; Yang, JS; Yang, SF; Yeh, CB; Yeh, LT, 2022)
"Niclosamide was found to induce the arrest of S and G2/M phase in U2OS cells and G2/M in MG-63 cells."1.42Niclosamide inhibits the proliferation of human osteosarcoma cell lines by inducing apoptosis and cell cycle arrest. ( Li, Z; Qi, B; Sun, S; Wang, W; Yu, A; Yu, Y, 2015)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Yeh, LT1
Lin, CW1
Lu, KH1
Hsieh, YH1
Yeh, CB1
Yang, SF1
Yang, JS1
Li, Z1
Yu, Y1
Sun, S1
Qi, B1
Wang, W1
Yu, A1
Liao, Z1
Nan, G1
Yan, Z1
Zeng, L1
Deng, Y1
Ye, J1
Zhang, Z1
Qiao, M1
Li, R1
Denduluri, S1
Wang, J1
Wei, Q1
Geng, N1
Zhao, L1
Lu, S1
Wang, X1
Zhou, G1
Luu, HH1
Haydon, RC1
He, TC1
Wang, Z1

Other Studies

3 other studies available for niclosamide and Osteosarcoma

ArticleYear
Niclosamide Suppresses Migration and Invasion of Human Osteosarcoma Cells by Repressing TGFBI Expression via the ERK Signaling Pathway.
    International journal of molecular sciences, 2022, Jan-01, Volume: 23, Issue:1

    Topics: Cell Death; Cell Line, Tumor; Cell Movement; Extracellular Matrix Proteins; Gene Knockdown Technique

2022
Niclosamide inhibits the proliferation of human osteosarcoma cell lines by inducing apoptosis and cell cycle arrest.
    Oncology reports, 2015, Volume: 33, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Bone Neoplasms; Cell Cycle Checkpoi

2015
The Anthelmintic Drug Niclosamide Inhibits the Proliferative Activity of Human Osteosarcoma Cells by Targeting Multiple Signal Pathways.
    Current cancer drug targets, 2015, Volume: 15, Issue:8

    Topics: Animals; Anthelmintics; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Cell Line, Tumor;

2015